Effects of the histone deacetylase inhibitor, trichostatin a, in a chronic allergic airways disease model in mice

Archivum Immunologiae et Therapiae Experimentalis

Volumn 60, Issue 4, 2012, Pages 295-306

  Royce, Simon G ^a,b   Dang, William ^a   Yuan, Gao ^a   Tran, Jenny ^a   El Osta, Assam ^a,c   Karagiannis, Tom C ^c   Tang, Mimi L K ^b  

^a MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

^c Epigenomic Medicine Group   (Australia)

Author keywords

Airway hyperresponsiveness; Airway remodeling; Asthma; Therapy; Trichostatin A

Indexed keywords

TRICHOSTATIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELLULAR DISTRIBUTION; CHRONIC DISEASE; CONTROLLED STUDY; DRUG EFFECT; EOSINOPHIL COUNT; FEMALE; GOBLET CELL; HISTOPATHOLOGY; INFLAMMATORY CELL; INVASIVE PROCEDURE; LUNG LAVAGE; LUNG PARENCHYMA; MORPHOMETRICS; MOUSE; NONHUMAN; PLETHYSMOGRAPHY; RESPIRATORY TRACT ALLERGY; TISSUE CHARACTERIZATION; TREATMENT RESPONSE;

AIRWAY REMODELING; ANIMALS; ASTHMA; BRONCHIAL HYPERREACTIVITY; BRONCHOALVEOLAR LAVAGE FLUID; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; EOSINOPHILS; FEMALE; HISTONE DEACETYLASE INHIBITORS; HUMANS; HYDROXAMIC ACIDS; LUNG; MICE; MICE, INBRED BALB C;

EID: 84866505345     PISSN: 0004069X     EISSN: 16614917     Source Type: Journal    
DOI: 10.1007/s00005-012-0180-3     Document Type: Article

References (54)

1. Adcock IM, Tsaprouni L, Bhavsar P et al (2007) Epigenetic regulation of airway inflammation. Curr Opin Immunol 19:694-700 (Pubitemid 350236802)
2. Belleguic C, Corbel M, Germain N et al (2002) Increased release of matrix metalloproteinase-9 in the plasma of acute severe asthmatic patients. Clin Exp Allergy 32:217-223 (Pubitemid 34429599)
3. Chakir J, Laviolette M, Boutet M et al (1996) Lower airways remodeling in nonasthmatic subjects with allergic rhinitis. Lab Investig 75:735-744 (Pubitemid 26392803)
4. Chetta A, Foresi A, Del Donno M et al (1997) Airways remodeling is a distinctive feature of asthma and is related to severity of disease. Chest 111:852-857 (Pubitemid 27171451)
5. Choi JH, Oh SW, Kang MS et al (2005) Trichostatin A attenuates airway inflammation in mouse asthma model. Clin Exp Allergy 35:89-96
6. Corteling R, Trifilieff A (2004) Gender comparison in a murine model of allergen-driven airway inflammation and the response to budesonide treatment. BMC Pharmacol 4:4
7. Covar RA, Spahn JD, Murphy JR et al (2004) Progression of asthma measured by lung function in the childhood asthma management program. Am J Respir Crit Care Med 170:234-241 (Pubitemid 38971407)
8. Dani C, Bonatto D, Salvador M et al (2008) Antioxidant protection of resveratrol and catechin in Saccharomyces cerevisiae. J Agric Food Chem 56:4268-4272 (Pubitemid 351967974)
9. Davies DE, Holgate ST (2002) Asthma: The importance of epithelial mesenchymal communication in pathogenesis. Inflammation and the airway epithelium in asthma. Int J Biochem Cell Biol 34: 1520-1526
10. Dombrowsky H, Barrenschee M, Kunze M et al (2009) Conserved responses to trichostatin A in rodent lungs exposed to endotoxin or stretch. Pulm Pharmacol Ther 22:593-602
11. Donnelly LE, Newton R, Kennedy GE et al (2004) Anti-inflammatory effects of resveratrol in lung epithelial cells: molecular mechanisms. Am J Physiol Lung Cell Mol Physiol 287:L774-L783 (Pubitemid 39249390)
12. el Assem SK, Peh KH, Wan BY et al (2008) Effects of a selection of histone deacetylase inhibitors on mast cell activation and airway and colonic smooth muscle contraction. Int Immunopharmacol 8:1793-1801
13. Fiscus LC, Van Herpen J, Steeber DA et al (2001) L-Selectin is required for the development of airway hyperresponsiveness but not airway inflammation in a murine model of asthma. J Allergy Clin Immunol 107:1019-1024 (Pubitemid 32523342)
14. Grabiec AM, Krausz S, de Jager W et al (2010) Histone deacetylase inhibitors suppress inflammatory activation of rheumatoid arthritis patient synovial macrophages and tissue. J Immunol 184:2718-2728
15. Hayashi T, Adachi Y, Hasegawa K et al (2003) Less sensitivity for late airway inflammation in males than females in BALB/c mice. Scand J Immunol 57:562-567 (Pubitemid 36734996)
16. Hemmatazad H, Rodrigues HM, Maurer B et al (2009) Histone deacetylase 7, a potential target for the antifibrotic treatment of systemic sclerosis. Arthritis Rheum 60:1519-1529
17. Hong Z, Han Z, Xiao M et al (2009) Microarray study of mechanism of trichostatin A inducing apoptosis of Molt-4 cells. J Huazhong Univ Sci Technol Med Sci 29:445-450
18. Hoshino M, Nakamura Y, Sim J et al (1998) Bronchial subepithelial fibrosis and expression of matrix metalloproteinase-9 in asthmatic airway inflammation. J Allergy Clin Immunol 102:783-788 (Pubitemid 28543528)
19. Huber LC, Distler JH, Moritz F et al (2007) Trichostatin A prevents the accumulation of extracellular matrix in a mouse model of bleomycin-induced skin fibrosis. Arthritis Rheum 56:2755-2764 (Pubitemid 47237295)
20. Kankaanranta H, Janka-Junttila M, Ilmarinen-Salo P et al (2010) Histone deacetylase inhibitors induce apoptosis in human eosinophils and neutrophils. J Inflamm 7:9
21. Keramidaris E, Merson TD, Steeber DA et al (2001) L-Selectin and intercellular adhesion molecule 1 mediate lymphocyte migration to the inflamed airway/lung during an allergic inflammatory response in an animal model of asthma. J Allergy Clin Immunol 107:734-738 (Pubitemid 32397766)
22. Kim SR, Lee KS, Park SJ et al (2010a) Involvement of sirtuin 1 in airway inflammation and hyperresponsiveness of allergic airway disease. J Allergy Clin Immunol 125:449-460
23. Kim TH, Jung JA, Kim GD et al (2010b) The histone deacetylase inhibitor, trichostatin A, inhibits the development of 2,4-dinitrofluorobenzene-induced dermatitis in NC/Nga mice. Int Immunopharmacol 10:1310-1315
24. Knight D (2001) Epithelium-fibroblast interactions in response to airway inflammation. Immunol Cell Biol 79:160-164 (Pubitemid 32281088)
25. Langley B, Brochier C, Rivieccio MA (2009) Targeting histone deacetylases as a multifaceted approach to treat the diverse outcomes of stroke. Stroke 40:2899-2905
26. Lekgabe ED, Royce SG, Hewitson TD et al (2006) The effects of relaxin and estrogen deficiency on collagen deposition and hypertrophy of nonreproductive organs. Endocrinology 147:5575-5583 (Pubitemid 44833474)
27. Leung DY, Szefler SJ (1998) New insights into steroid resistant asthma. Pediatr Allergy Immunol 9:3-12 (Pubitemid 28142350)
28. Locke NR, Royce SG, Wainewright JS et al (2007) Comparison of airway remodeling in acute, subacute, and chronic models of allergic airways disease. Am J Respir Cell Mol Biol 36:625-632 (Pubitemid 46676722)
29. Marks PA (2010) The clinical development of histone deacetylase inhibitors as targeted anticancer drugs. Expert Opin Investig Drugs 19:1049-1066
30. Marks PA, Breslow R (2007) Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug. Nat Biotechnol 25:84-90 (Pubitemid 46087907)
31. Melgert BN, Postma DS, Kuipers I et al (2005) Female mice are more susceptible to the development of allergic airway inflammation than male mice. Clin Exp Allergy 35:1496-1503
32. Michaelis M, Michaelis UR, Fleming I et al (2004) Valproic acid inhibits angiogenesis in vitro and in vivo. Mol Pharmacol 65:520-527 (Pubitemid 38264019)
33. Mookerjee I, Solly NR, Royce SG et al (2006) Endogenous relaxin regulates collagen deposition in an animal model of allergic airway disease. Endocrinology 147:754-761 (Pubitemid 43112991)
34. Ordonez CL, Khashayar R, Wong HH et al (2001) Mild and moderate asthma is associated with airway goblet cell hyperplasia and abnormalities in mucin gene expression. Am J Respir Crit Care Med 163:517-523 (Pubitemid 32158539)
35. Phunek P, Roche WR, Turzikova J et al (1997) Eosinophilic inflammation in the bronchial mucosa of children with bronchial asthma. Eur Respir J 19:160s
36. Place RF, Noonan EJ, Giardina C (2005) HDACs and the senescent phenotype of WI-38 cells. BMC Cell Biol 6:37
37. Royce SG, Tang ML (2009) The effects of current therapies on airway remodeling in asthma and new possibilities for treatment and prevention. Curr Mol Pharmacol 2:169-181
38. Royce SG, Miao YR, Lee M et al (2009) Relaxin reverses airway remodeling and airway dysfunction in allergic airways disease. Endocrinology 150:2692-2699
39. Sambucetti LC, Fischer DD, Zabludoff S et al (1999) Histone deacetylase inhibition selectively alters the activity and expression of cell cycle proteins leading to specific chromatin acetylation and antiproliferative effects. J Biol Chem 274:34940-34947 (Pubitemid 129509542)
40. Samuel CS, Zhao C, Bathgate RA et al (2003) Relaxin deficiency in mice is associated with an age-related progression of pulmonary fibrosis. FASEB J 17:121-123
41. Samuel CS, Royce SG, Burton MD et al (2007) Relaxin plays an important role in the regulation of airway structure and function. Endocrinology 148:4259-4266 (Pubitemid 47295681)
42. Samuel CS, Royce SG, Chen B et al (2009) Relaxin family peptide receptor-1 protects against airway fibrosis during homeostasis but not against fibrosis associated with chronic allergic airways disease. Endocrinology 150:1495-1502
43. Sanders YY, Tollefsbol TO, Varisco BM et al (2011) Epigenetic regulation of Thy-1 by histone deacetylase inhibitor in rat lung fibroblasts. Am J Respir Cell Mol Biol 45:16-23
44. Shankar S, Srivastava RK (2008) Histone deacetylase inhibitors: mechanisms and clinical significance in cancer: HDAC inhibitorinduced apoptosis. Adv Exp Med Biol 615:261-298
45. Tang ML, Wilson JW, Stewart AG et al (2006) Airway remodelling in asthma: current understanding and implications for future therapies. Pharmacol Ther 112:474-488 (Pubitemid 44486410)
46. Temelkovski J, Hogan SP, Shepherd DP et al (1998) An improved murine model of asthma: Selective airway inflammation, epithelial lesions and increased methacholine responsiveness following chronic exposure to aerosolised allergen. Thorax 53:849-856 (Pubitemid 28459541)
47. Vanhaecke T, Papeleu P, Elaut G et al (2004) Trichostatin A-like hydroxamate histone deacetylase inhibitors as therapeutic agents: Toxicological point of view. Curr Med Chem 11:1629-1643 (Pubitemid 38735799)
48. Wang L, Tao R, Hancock WW (2009) Using histone deacetylase inhibitors to enhance Foxp3(?) regulatory T-cell function and induce allograft tolerance. Immunol Cell Biol 87:195-202
49. Ward C, Walters H (2005) Airway wall remodelling: The influence of corticosteroids. Curr Opin Allergy Clin Immunol 5:43-48 (Pubitemid 40175495)
50. Warner JO, Pohunek P, Marguet C et al (2000) Progression from allergic sensitization to asthma. Pediatr Allergy Immunol 11(Suppl 13):12-14
51. Westergren-Thorsson G, Larsen K, Nihlberg K et al (2010) Pathological airway remodelling in inflammation. Clin Respir J 4(Suppl 1):1-8
52. Wolffe AP, Kurumizaka H (1998) The nucleosome: A powerful regulator of transcription. Prog Nucleic Acid Res Mol Biol 61:379-422
53. XuWS, Parmigiani RB,Marks PA(2007)Histone deacetylase inhibitors: molecular mechanisms of action. Oncogene 26:5541-5552 (Pubitemid 47255934)
54. Zhang Z, Zhang ZY, Fauser U et al (2008) Valproic acid attenuates inflammation in experimental autoimmune neuritis. Cell Mol Life Sci 65:4055-4065